miRNA-130a-3p/CPEB4 Axis Modulates Glioblastoma Growth and Progression.

Area of Science:

• Molecular Biology
• Oncology
• Biochemistry

Background:

• Glioblastoma is the most common malignant brain tumor.
• Cytoplasmic polyadenylation element binding protein 4 (CPEB4) is overexpressed and promotes glioblastoma tumorigenesis and metastasis.
• MicroRNA-130a-3p (miR-130a-3p) expression is altered in tumors, warranting investigation.

Purpose of the Study:

• To investigate the role and mechanism of miR-130a-3p in glioblastoma proliferation and migration.
• To explore the regulatory relationship between miR-130a-3p and CPEB4 in glioblastoma.

Main Methods:

• Quantitative real-time PCR to detect miR-130a-3p and CPEB4 expression.
• Cell viability (MTT assay), migration (Transwell assay), and cell cycle (flow cytometry) analyses.
• Western blotting for CPEB4 protein and epithelial-mesenchymal transition (EMT) markers.
• Bioinformatics and luciferase reporter assays to confirm miR-130a-3p targeting of CPEB4.

Main Results:

• CPEB4 was upregulated, while miR-130a-3p was downregulated in glioblastoma cell lines.
• miR-130a-3p directly targets and downregulates CPEB4 expression.
• Increased miR-130a-3p suppressed glioblastoma cell proliferation, migration, and EMT.
• CPEB4 overexpression counteracted the inhibitory effects of miR-130a-3p.

Conclusions:

• Downregulation of miR-130a-3p leads to CPEB4 upregulation in glioblastoma.
• The miR-130a-3p/CPEB4 axis significantly influences glioblastoma growth and migration.
• Targeting the miR-130a-3p/CPEB4 pathway presents a potential therapeutic strategy for glioblastoma.